207 related articles for article (PubMed ID: 35139770)
1. Spectroscopic observations of β-eudesmol binding to human cytochrome P450 isoforms 3A4 and 1A2, but not to isoforms 2C9, 2C19, and 2D6.
Krenc D; Na-Bangchang K
Xenobiotica; 2022 Feb; 52(2):199-208. PubMed ID: 35139770
[TBL] [Abstract][Full Text] [Related]
2. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib.
Uttamsingh V; Lu C; Miwa G; Gan LS
Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
4.
Zhang N; Liu J; Chen Z; Dou W
Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
[No Abstract] [Full Text] [Related]
5. The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β-eudesmol in human liver: Reaction phenotyping and enzyme kinetics.
Muhamad N; Na-Bangchang K
Pharmacol Res Perspect; 2023 Dec; 11(6):e01149. PubMed ID: 37902256
[TBL] [Abstract][Full Text] [Related]
6. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibitory effects of pristimerin on human liver cytochrome P450 enzymes.
Hao X; Yuan J; Xu Y; Wang Z; Hou J; Hu T
Xenobiotica; 2018 Dec; 48(12):1185-1191. PubMed ID: 28385095
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4.
Jin C; He X; Zhang F; He L; Chen J; Wang L; An L; Fan Y
Xenobiotica; 2015; 45(7):571-7. PubMed ID: 25811791
[TBL] [Abstract][Full Text] [Related]
9. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
[TBL] [Abstract][Full Text] [Related]
10. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.
Rastogi H; Jana S
Phytother Res; 2014 Dec; 28(12):1873-8. PubMed ID: 25196644
[TBL] [Abstract][Full Text] [Related]
12. Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator.
Jornil J; Jensen KG; Larsen F; Linnet K
Drug Metab Dispos; 2010 Mar; 38(3):376-85. PubMed ID: 20007670
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
[TBL] [Abstract][Full Text] [Related]
14. Development of a method to determine cytochrome P450 1A2, 2C9, 2D6 and 3A4 activity sheep hepatic microsomes.
McBride GM; Soo JY; Varcoe T; Morrison JL; Wiese MD
J Pharmacol Toxicol Methods; 2020; 106():106934. PubMed ID: 33080390
[TBL] [Abstract][Full Text] [Related]
15. The Effects of AT-533 and AT-533 gel on Liver Cytochrome P450 Enzymes in Rats.
Wu Y; Li M; Guo Y; Liu T; Zhong L; Huang C; Ye C; Liu Q; Ren Z; Wang Y
Eur J Drug Metab Pharmacokinet; 2022 May; 47(3):345-352. PubMed ID: 35137361
[TBL] [Abstract][Full Text] [Related]
16. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.
Fasinu PS; Bouic PJ; Rosenkranz B
Afr J Tradit Complement Altern Med; 2014; 11(4):54-61. PubMed ID: 25392581
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin.
Habenschus MD; Moreira FL; Lopes NP; de Oliveira ARM
Planta Med; 2017 May; 83(8):727-736. PubMed ID: 28073119
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of a New Antiaggregant, Indolinone Derivative.
Bykov VV; Leonov KA; Serebrov VY; Chernysheva GA; Smol'yakova VI; Solov'ev MA; Udut EV; Fisenko VP; Udut VV
Bull Exp Biol Med; 2020 Apr; 168(6):739-742. PubMed ID: 32333310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
